First Trust Advisors’s Accelerate Diagnostics AXDX Stock Holding History

First Trust Advisors’s Portfolio AXDX Stock Details AXDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-8,986	Closed	-$958K	–	2313
2020 Q3	$958K	Buy	+8,986	New	+$1.25M	﹤0.01%	1777
2020 Q2	–	Sell	-1,405	Closed	-$117K	–	2363
2020 Q1	$117K	Buy	+1,405	New	+$198K	﹤0.01%	2285
2019 Q4	–	Sell	-13,109	Closed	-$2.43M	–	2385
2019 Q3	$2.43M	Buy	13,109 +1,876	+17%	+$363K	﹤0.01%	1427
2019 Q2	$2.57M	Buy	+11,233	New	+$2.2M	﹤0.01%	1422
2019 Q1	–	Sell	-4,152	Closed	-$477K	–	2409
2018 Q4	$477K	Buy	+4,152	New	+$615K	﹤0.01%	2143
2018 Q3	–	Sell	-3,361	Closed	-$750K	–	2433
2018 Q2	$750K	Sell	3,361 -3,192	-49%	-$714K	﹤0.01%	2032
2018 Q1	$1.5M	Buy	+6,553	New	+$1.72M	﹤0.01%	1625
2017 Q4	–	Sell	-8,880	Closed	-$1.99M	–	2384
2017 Q3	$1.99M	Buy	8,880 +4,458	+101%	+$1.09M	0.01%	1473
2017 Q2	$1.21M	Buy	+4,422	New	+$1.2M	﹤0.01%	1766
2017 Q1	–	Sell	-8,011	Closed	-$1.66M	–	2382
2016 Q4	$1.66M	Buy	+8,011	New	+$1.9M	﹤0.01%	1561

Other funds holding AXDX

OIM

Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Birchview Capital Burlington, Vermont $214M AUM 185.33% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Axa Paris, France $91.9M AUM 27.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Chicago Capital Chicago, Illinois $4.32B AUM 31.14% 1-Year Est. Return

GAM

Griffin Asset Management New York $949M AUM 24.98% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Cannell & Co New York $3.15B AUM 30.62% 1-Year Est. Return

First Trust Advisors's AXDX Position: Q4 2020 in Review

First Trust Advisors sold out of Accelerate Diagnostics (AXDX) in Q4 2020, closing a stake of 8,986 shares — an estimated $958K sold.

First Trust Advisors first reported a position in AXDX in Q4 2016 and held it in 10 quarters. The position peaked at $2.57M in Q2 2019. 115 funds tracked by Wall St. Rank hold AXDX as of Q4 2020.

First Trust Advisors reported no remaining Accelerate Diagnostics position as of Q4 2020 after selling out during the quarter.
First Trust Advisors sold 8,986 Accelerate Diagnostics shares in Q4 2020, an estimated $958K.
First Trust Advisors first reported a position in Accelerate Diagnostics in Q4 2016 and held it in 10 quarters.
First Trust Advisors's Accelerate Diagnostics position peaked at $2.57M in Q2 2019.
115 funds tracked by Wall St. Rank held Accelerate Diagnostics as of Q4 2020.

Based on First Trust Advisors's 13F filing for Q4 2020, filed 2 Feb 2021.